The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.67 in the prior trading day, Vor Biopharma Inc (NASDAQ: VOR) closed at $0.69, up 2.80%. In other words, the price has increased by $2.80 from its previous closing price. On the day, 1.15 million shares were traded. VOR stock price reached its highest trading level at $0.75 during the session, while it also had its lowest trading level at $0.6653.
Ratios:
Our goal is to gain a better understanding of VOR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.54 and its Current Ratio is at 6.54. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on July 26, 2022, initiated with a Outperform rating and assigned the stock a target price of $18.
On April 27, 2022, Goldman started tracking the stock assigning a Neutral rating and target price of $6.
On December 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $26.H.C. Wainwright initiated its Buy rating on December 17, 2021, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’24 when Attar Eyal C. sold 14,645 shares for $1.39 per share. The transaction valued at 20,357 led to the insider holds 96,063 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 47202012 and an Enterprise Value of -4915970.
Stock Price History:
Over the past 52 weeks, VOR has reached a high of $3.14, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -21.50%, while the 200-Day Moving Average is calculated to be -56.25%.
Shares Statistics:
The stock has traded on average 829.68K shares per day over the past 3-months and 706420 shares per day over the last 10 days, according to various share statistics. A total of 67.89M shares are outstanding, with a floating share count of 59.59M. Insiders hold about 12.87% of the company’s shares, while institutions hold 68.87% stake in the company. Shares short for VOR as of 1726185600 were 2538934 with a Short Ratio of 3.06, compared to 1723680000 on 1663439. Therefore, it implies a Short% of Shares Outstanding of 2538934 and a Short% of Float of 6.81.
